Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors. [electronic resource]
Producer: 20181002Description: 177-188 p. digitalISSN:- 1791-2423
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cholangiocarcinoma -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Estrogen Receptor beta -- agonists
- Estrogens -- metabolism
- Gene Expression Regulation, Neoplastic -- drug effects
- Genistein -- administration & dosage
- Humans
- Interleukin-6 -- genetics
- Oncogene Protein v-akt -- antagonists & inhibitors
- Phosphorylation
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.